Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation.
Nonadherence of transplant recipients to prescribed medical regimens has been identified as a major cause of allograft failure. Although recent studies offer new insight into the clinical phenotypes of nonadherence, advances in defining risk factors and appropriate interventions have been limited because of variable definitions, inadequate clinical metrics, and the challenges associated with healthcare delivery. Significant nonadherence is estimated to occur in 22% of renal allograft recipients and may be a component of allograft loss in approximately 36% of patients. It is associated with increased incidence of rejection (acute and chronic) and, consequently, shortened renal allograft survival, requiring reinstitution of costly chronic renal replacement therapy with an incumbent effect on morbidity and mortality. The economic effect of nonadherence approaches similar magnitude. Identification of risk factors, coupled with measures that effectively address them, can have a positive effect at many levels--medically, socially, and economically. Further advances are likely to be dependent on improving interactions between patients and caregivers, broadening immunosuppressant availability, and newer therapeutics that move toward simpler regimens.
Prendergast
Mary B
MB
Department of Medicine, Division of Nephrology, 625 THT, University of Alabama at Birmingham, 1530 Third Avenue South, Birmingham, AL 35294-0006, USA. mbprende@uab.edu
Gaston
Robert S
RS
D017046:Cost Savings; D006084:Graft Rejection / Q000191:economics / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects*; D015438:Health Behavior; D017048:Health Care Costs; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects / Q000191:economics; D055118:Medication Adherence; D012307:Risk Factors; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D007166:Immunosuppressive Agents
Am J Transplant. 2007 Feb;7(2):408-15
17229080
Transpl Int. 2005 Oct;18(10):1121-33
16162098
J Am Soc Nephrol. 2005 Jun;16(6):1839-48
15800121
Transplantation. 2009 Mar 15;87(5):711-8
19295316
N Engl J Med. 2000 Nov 23;343(21):1545-52
11087885
N Engl J Med. 1992 Sep 17;327(12):840-5
1508243
Am J Transplant. 2007 Jul;7(7):1770-7
17564637
Am J Health Syst Pharm. 2003 Feb 1;60(3):266-9
12613236
Transplant Proc. 1999 Jun;31(4A):21S-23S
10372038
Transpl Int. 2006 Apr;19(4):342-3
16573552
Transplantation. 2009 Sep 15;88(5):736-46
19741474
Clin Transplant. 2007 May-Jun;21(3):344-51
17488383
Kidney Int. 2000 Sep;58(3):1311-7
10972695
Br J Clin Pharmacol. 2002 Aug;54(2):212-20
12207644
Eur J Cardiovasc Nurs. 2003 Dec;2(4):323
14667488
Am J Transplant. 2004 Sep;4(9):1509-13
15307839
Ther Clin Risk Manag. 2009 Feb;5(1):209-16
19436625
BMC Med Res Methodol. 2008 Feb 19;8:5
18284675
Am J Transplant. 2007 Jun;7(6):1609-15
17511684
N Engl J Med. 2005 Aug 25;353(8):770-81
16120857
Clin Ther. 2001 Aug;23(8):1296-310
11558866
Transplantation. 2008 Jan 27;85(2):193-202
18212623
Am J Geriatr Pharmacother. 2008 Dec;6(5):255-63
19161928
Transplant Proc. 1994 Oct;26(5):2538-41
7940782
Am J Transplant. 2008 Mar;8(3):616-26
18294158
Ann Pharmacother. 2002 Sep;36(9):1331-6
12196047
Pharmacoeconomics. 2004;22(18):1217-34
15606228
Value Health. 2003 Sep-Oct;6(5):566-73
14627063
Ann Pharmacother. 1993 Sep;27(9 Suppl):S1-24
8400462
Transplantation. 1998 Dec 27;66(12):1718-26
9884266
Am J Transplant. 2009 Jun;9(6):1337-46
19459828
Transplantation. 2007 Apr 15;83(7):858-73
17460556
JAMA. 2002 Jul 24-31;288(4):462-7
12132976
Clin Transplant. 2005 Feb;19(1):77-82
15659138
Pediatr Transplant. 2009 Aug;13(5):590-8
18992064
Am J Transplant. 2007 Jan;7(1):108-16
17109727
Transplantation. 2009 May 27;87(10):1497-504
19461486
Clin Pharmacol Ther. 2000 Dec;68(6):586-91
11180017
Transpl Int. 2009 May;22(5):534-45
19175560
Transplantation. 2004 Mar 15;77(5):786-9
15021850
J Psychosom Res. 2009 Feb;66(2):101-10
19154852
Transplant Proc. 1988 Jun;20(3 Suppl 3):63-9
3291299
Pediatr Transplant. 2006 May;10(3):304-10
16677353
Kidney Int. 2001 Oct;60(4):1565-70
11576374
Am J Med. 2003 Jun 1;114(8):625-30
12798449
Liver Transpl. 2008 Feb;14(2):159-72
18236389
Am J Transplant. 2009 Nov;9(11):2597-606
19843035
JAMA. 2002 Dec 11;288(22):2880-3
12472330
J Am Soc Nephrol. 2000 Jun;11(6):1122-1131
10820177
Am J Health Syst Pharm. 2001 Jun 15;58(12):1126-32
11449856
Transpl Int. 2009 Aug;22(8):780-97
19386076
Transpl Int. 2009 Apr;22(4):441-6
19144090
Encephale. 2002 May-Jun;28(3 Pt 1):266-72
12091789
Am J Transplant. 2001 May;1(1):69-73
12095042
Am J Transplant. 2009 Jan;9(1):35-41
19133930
Clin Ther. 2003 Aug;25(8):2307-35; discussion 2306
14512137
Manag Care Interface. 1998 Sep;11(9):67-9, 75
10187590
Am J Geriatr Pharmacother. 2009 Apr;7(2):105-16
19447363
Pediatr Transplant. 2007 Sep;11(6):608-14
17663682
Drugs. 2007;67(13):1944-5
17722963
Am J Transplant. 2004 Jul;4(7):1033-41
15196059
Am J Transplant. 2009 Nov;9(11):2497-504
19681814